MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 24.88
+0.76 (3.15%)
Aug 21, 2026, 5:35 PM CET
MedinCell Employees
MedinCell had 141 employees as of March 31, 2026. The number of employees increased by 10 or 7.63% compared to the previous year.
Employees
141
Change
10
Growth
7.63%
Revenue / Employee
€172,177
Profits / Employee
€221,894
Market Cap
893.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 141 | 10 | 7.63% |
| Mar 31, 2025 | 131 | -3 | -2.24% |
| Mar 31, 2024 | 134 | 3 | 2.29% |
| Mar 31, 2023 | 131 | -8 | -5.76% |
| Mar 31, 2022 | 139 | 1 | 0.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| Cellectis | 229 |
| DBV Technologies | 170 |
| Innate Pharma | 164 |
| Genfit | 161 |
| Transgene | 145 |
| Nanobiotix | 100 |
| ABIVAX Société Anonyme | 80 |
MedinCell News
- 11 days ago - Medincell's Dr Grace Kim to Participate in Piper Sandler CNS Symposium - Business Wire
- 25 days ago - Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook - Business Wire
- 26 days ago - Medincell Continues to Strengthen and Renew its Board of Directors with the Proposed Appointment of Dr. Elisabeth Svanberg - Business Wire
- 5 weeks ago - Medincell Aligns Debt Maturity with Its Expected Revenue Growth Trajectory - Business Wire
- 2 months ago - MedinCell Slides: Corporate presentation - Filings
- 2 months ago - MedinCell Transcript: H2 25/26 - Transcripts
- 2 months ago - MedinCell Earnings release: H2 2026 - Filings
- 2 months ago - MedinCell Slides: H2 2026 - Filings